BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12869209)

  • 1. Molecular surveillance of the antifolate-resistant mutation I164L in imported African isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEurop.
    Wichmann O; Jelinek T; Peyerl-Hoffmann G; Mühlberger N; Grobusch MP; Gascon J; Matteelli A; Hatz C; Laferl H; Schulze M; Burchard G; da Cunha S; Beran J; McWhinney P; Kollaritsch H; Kern P; Cuadros J; Alifrangis M; Gjørup I;
    Malar J; 2003 Jun; 2():17. PubMed ID: 12869209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation.
    Hamel MJ; Poe A; Bloland P; McCollum A; Zhou Z; Shi YP; Ouma P; Otieno K; Vulule J; Escalante A; Udhayakumar V; Slutsker L
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):338-45. PubMed ID: 18321547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
    Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
    Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
    Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
    Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa.
    Maïga O; Djimdé AA; Hubert V; Renard E; Aubouy A; Kironde F; Nsimba B; Koram K; Doumbo OK; Le Bras J; Clain J
    J Infect Dis; 2007 Jul; 196(1):165-72. PubMed ID: 17538897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring the drug-sensitivity of Plasmodium falciparum in coastal towns in Madagascar by use of in vitro chemosensitivity and mutation detection tests.
    Rason MA; Ariey F; Rafidimanantsoa L; Andrianantenaina BH; Sahondra Harisoa JL; Randrianarivelojosia M
    Parasite; 2002 Sep; 9(3):247-53. PubMed ID: 12375368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.
    Mita T; Ohashi J; Venkatesan M; Marma AS; Nakamura M; Plowe CV; Tanabe K
    J Infect Dis; 2014 Jan; 209(1):130-9. PubMed ID: 23922363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
    Alifrangis M; Enosse S; Khalil IF; Tarimo DS; Lemnge MM; Thompson R; Bygbjerg IC; Rønn AM
    Am J Trop Med Hyg; 2003 Dec; 69(6):601-6. PubMed ID: 14740875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare, highly pyrimethamine-resistant alleles of the Plasmodium falciparum dihydrofolate reductase gene from 5 African sites.
    Bates SJ; Winstanley PA; Watkins WM; Alloueche A; Bwika J; Happi TC; Kremsner PG; Kublin JG; Premji Z; Sibley CH
    J Infect Dis; 2004 Nov; 190(10):1783-92. PubMed ID: 15499534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.
    Alker AP; Mwapasa V; Purfield A; Rogerson SJ; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3919-21. PubMed ID: 16127071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
    Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
    Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.
    Alam MT; Bora H; Bharti PK; Saifi MA; Das MK; Dev V; Kumar A; Singh N; Dash AP; Das B; Wajihullah ; Sharma YD
    Antimicrob Agents Chemother; 2007 Mar; 51(3):857-63. PubMed ID: 17194833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
    Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
    Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resistance to chloroquine and cycloguanil of Plasmodium falciparum in patients arriving in France after travel in Africa without chemoprophylaxis].
    Le Bras J; Pradines B; di Piazza JP; Durand R; Godineau N; Bouchaud O; Roué R; Marchou B; Martet G; Longuet C; Parzy D
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):490-2. PubMed ID: 10078392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular surveillance system for global patterns of drug resistance in imported malaria.
    Labbé AC; Patel S; Crandall I; Kain KC
    Emerg Infect Dis; 2003 Jan; 9(1):33-6. PubMed ID: 12533279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
    Krudsood S; Imwong M; Wilairatana P; Pukrittayakamee S; Nonprasert A; Snounou G; White NJ; Looareesuwan S
    Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):142-9. PubMed ID: 15607340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases.
    Jelinek T; Schulte C; Behrens R; Grobusch MP; Coulaud JP; Bisoffi Z; Matteelli A; Clerinx J; Corachán M; Puente S; Gjørup I; Harms G; Kollaritsch H; Kotlowski A; Björkmann A; Delmont JP; Knobloch J; Nielsen LN; Cuadros J; Hatz C; Beran J; Schmid ML; Schulze M; Lopez-Velez R; Fleischer K; Kapaun A; McWhinney P; Kern P; Atougia J; Fry G; da Cunha S; Boecken G
    Clin Infect Dis; 2002 Mar; 34(5):572-6. PubMed ID: 11803507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America.
    Cortese JF; Caraballo A; Contreras CE; Plowe CV
    J Infect Dis; 2002 Oct; 186(7):999-1006. PubMed ID: 12232841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifolate antimalarial resistance in southeast Africa: a population-based analysis.
    Roper C; Pearce R; Bredenkamp B; Gumede J; Drakeley C; Mosha F; Chandramohan D; Sharp B
    Lancet; 2003 Apr; 361(9364):1174-81. PubMed ID: 12686039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea.
    Mita T; Kaneko A; Hwaihwanje I; Tsukahara T; Takahashi N; Osawa H; Tanabe K; Kobayakawa T; Björkman A
    Infect Genet Evol; 2006 Nov; 6(6):447-52. PubMed ID: 16600696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.